$139.380
+1.310 (+0.94%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Protagonist Therapeutics Inc (PTGX) Moving Averages Convergence Divergence (MACD) indicator is -1.73, suggesting PTGX is Buy.
Protagonist Therapeutics Inc (PTGX) 20-Day simple moving average is 139.21, while Protagonist Therapeutics Inc (PTGX) share price is $—, making it Buy.
Protagonist Therapeutics Inc (PTGX) 60-Day simple moving average is 144.11, while Protagonist Therapeutics Inc (PTGX) share price is $—, making it Sell.
Technical Analysis for PTGX
AI Technical PTGXAs of 2026-10-17, the technical board for Protagonist Therapeutics Inc (PTGX) reads buy: 5 indicators are flashing buy, 4 are indicating sell, and 4 are neutral. Price at $139.53 sits below the 60-day moving averages and above the 5-day, 10-day, 20-day and 200-day.
Momentum readings: RSI stands at 49.533, MACD stands at -1.725 (Sell), Stochastic %K stands at 47.076, Stochastic %D stands at 38.672 and CCI stands at -15.792.
PTGX trades below the 60-day SMA (144.11) and above the 200-day SMA (114.81). Immediate resistance sits at Classic R1 151.24, then R2 164.61. Support sits at Classic S1 125.45, then S2 113.02.
Protagonist Therapeutics Inc (PTGX) Support & Resistance Level
Protagonist Therapeutics Inc (PTGX) Technical Indicators
2026-10-17
| Name | Value |
|---|---|
| RSI_14 | 49.533 |
| STOCHk_14_3_3 | 47.076 |
| STOCHd_14_3_3 | 38.672 |
| CCI_20 | -15.792 |
| AO_5_34 | -5.883 |
| MOM_10 | -0.380 |
| MACD_12_26_9 | -1.725 |
Protagonist Therapeutics Inc (PTGX) Relative Strength Index (RSI_14) is 49.533, creating a Neutral signal.
Protagonist Therapeutics Inc (PTGX) Stochastic %K is 47.076, creating a Neutral signal.
Protagonist Therapeutics Inc (PTGX) Stochastic %D is 38.672, creating a Neutral signal.
Protagonist Therapeutics Inc (PTGX) CCI_20 is -15.792, creating a Neutral signal.
Protagonist Therapeutics Inc (PTGX) Awesome Oscillator (AO) is -5.883, creating a Sell signal.
Protagonist Therapeutics Inc (PTGX) Momentum (MOM) is -0.380, creating a Sell signal.
Protagonist Therapeutics Inc (PTGX) Moving Average Convergence Divergence (MACD) is -1.725, creating a Sell signal.
Protagonist Therapeutics Inc (PTGX) Moving Average
2026-10-17
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 135.758 | Buy |
| MA_10 | 137.872 | Buy |
| MA_20 | 139.214 | Buy |
| MA_60 | 144.107 | Sell |
| MA_200 | 114.814 | Buy |
| MA_250 | 108.903 | Buy |
Protagonist Therapeutics Inc (PTGX) 5-Day simple moving average is 135.758, while Protagonist Therapeutics Inc (PTGX) share price is $, making it a Buy.
Protagonist Therapeutics Inc (PTGX) 10-Day simple moving average is 137.872, while Protagonist Therapeutics Inc (PTGX) share price is $, making it a Buy.
Protagonist Therapeutics Inc (PTGX) 20-Day simple moving average is 139.214, while Protagonist Therapeutics Inc (PTGX) share price is $, making it a Buy.
Protagonist Therapeutics Inc (PTGX) 60-Day simple moving average is 144.107, while Protagonist Therapeutics Inc (PTGX) share price is $, making it a Sell.
Protagonist Therapeutics Inc (PTGX) 200-Day simple moving average is 114.814, while Protagonist Therapeutics Inc (PTGX) share price is $, making it a Buy.
Protagonist Therapeutics Inc (PTGX) 250-Day simple moving average is 108.903, while Protagonist Therapeutics Inc (PTGX) share price is $, making it a Buy.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.